Scarica l'app Stockscreener
2.90
0.00%
0.00
Dopo l'orario di chiusura:
2.97
0.07
+2.41%
Precedente Chiudi:
$2.90
Aprire:
$2.9
Volume 24 ore:
1.85M
Relative Volume:
1.27
Capitalizzazione di mercato:
$432.10M
Reddito:
$181.41M
Utile/perdita netta:
$-59.56M
Rapporto P/E:
-5.5769
EPS:
-0.52
Flusso di cassa netto:
$-38.83M
1 W Prestazione:
+1.40%
1M Prestazione:
+7.81%
6M Prestazione:
+36.15%
1 anno Prestazione:
+45.73%
Intervallo 1D:
$2.8303
$3.0425
Intervallo di 1 settimana:
$2.82
$3.0425
Portata 52W:
$1.46
$3.26
Xeris Biopharma Holdings Inc Stock (XERS) Company Profile
Nome
Xeris Biopharma Holdings Inc
Settore
Industria
Telefono
844-445-5704
Indirizzo
1375 WEST FULTON STREET, SUITE 1300, CHICAGO, IL
Xeris Biopharma Holdings Inc Stock (XERS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-10-21 | Iniziato | Jefferies | Buy |
| 2022-04-28 | Iniziato | Craig Hallum | Buy |
| 2021-11-17 | Iniziato | SVB Leerink | Outperform |
| 2021-10-29 | Iniziato | H.C. Wainwright | Buy |
| 2021-04-07 | Ripresa | RBC Capital Mkts | Outperform |
| 2020-02-18 | Iniziato | Piper Sandler | Overweight |
| 2018-07-16 | Iniziato | Jefferies | Buy |
| 2018-07-16 | Iniziato | Leerink Partners | Outperform |
| 2018-07-16 | Iniziato | RBC Capital Mkts | Outperform |
Mostra tutto
Xeris Biopharma Holdings Inc Borsa (XERS) Ultime notizie
Analytical Lens: Exploring Xeris Biopharma Holdings Inc (XERS)’s Financial Story Through Ratios - The Dwinnex
Xeris Biopharma Holdings Inc (XERS) Becoming More Attractive for Investors - Knox Daily
Financial Analysis: Lexaria Bioscience (NASDAQ:LEXX) & Xeris Biopharma (NASDAQ:XERS) - Defense World
Healthy Upside Potential: Xeris Biopharma Holdings Inc (XERS) - SETE News
Principal Financial Group Inc. Sells 10,992 Shares of Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World
Xeris Biopharma Holdings Inc [XERS] stock for 10,147 USD was bought by Schmid John P. - Knox Daily
Xeris Biopharma Holdings Inc [XERS] Revenue clocked in at $181.41 million, up 21.70% YTD: What’s Next? - The DBT News
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) most popular amongst individual investors who own 53% of the shares, institutions hold 43% - Yahoo Finance
XERS: Riding the Market Waves of Growth and Decline in 2023 - The InvestChronicle
The Potential Rise in the Price of Xeris Biopharma Holdings Inc (XERS) following insiders activity - Knox Daily
Xeris Biopharma Holdings Inc (XERS) requires closer examination - US Post News
Trading Day Review: Xeris Biopharma Holdings Inc (XERS) Gains Momentum, Closing at 2.67 - The Dwinnex
Allspring Global Investments Holdings LLC Boosts Stake in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Could Be Riskier Than It Looks - Simply Wall St
Taking a look at what insiders are doing to gauge the Xeris Biopharma Holdings Inc (XERS)’s direction - Knox Daily
Xeris Biopharma Holdings Inc (XERS) Stock: A Year of Market Movement, Down and Up - The InvestChronicle
A History of Outperforming Analyst Forecasts and Beating the Odds: Xeris Biopharma Holdings Inc (XERS) - SETE News
Examining Xeris Biopharma Holdings Inc (XERS) stock is warranted - US Post News
Xeris Biopharma Holdings Inc [XERS] Records 200-Day SMA of $2.27 - Knox Daily
Xeris Biopharma Holdings Inc (XERS) shows promising results - US Post News
Understanding the Risks of Investing in Xeris Biopharma Holdings Inc (XERS) - Knox Daily
Trading Day Triumph: Xeris Biopharma Holdings Inc (XERS) Ends at 2.88, a 2.86 Surge/Plunge - The Dwinnex
The time has not yet come to remove your chips from the table: Xeris Biopharma Holdings Inc (XERS) - SETE News
This Data Shows Just How Strong Xeris Biopharma Holdings Inc (NASDAQ: XERS) Stock Is - Stocks Register
Xeris Biopharma Holdings Inc’s Shares Reel: 48.97% Quarterly Revenue Decline Amid 432.84M Market Cap - The InvestChronicle
Xeris Biopharma Holdings Inc [XERS] Records 50-Day SMA of $2.35 - Knox Daily
Xeris Biopharma Holdings Inc (XERS) Stock: A Year of Stock Market Dynamics - The InvestChronicle
Xeris to Participate in Upcoming Investor Conferences - StockTitan
Xeris to Participate in Upcoming Investor Conferences - Business Wire
Gaining Ground: Xeris Biopharma Holdings Inc (XERS) Closes Lower at 2.70, Down -0.74 - The Dwinnex
How should investors view Xeris Biopharma Holdings Inc (XERS)? - US Post News
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Shares Sold by California State Teachers Retirement System - Defense World
Xeris Biopharma And 2 Other Penny Stocks Insiders Are Buying - MSN
Investing in Xeris Biopharma Holdings Inc (XERS): What You Must Know - Knoxdaily.com
XERS (Xeris Biopharma Holdings) EPS (Basic) : $-0.42 (TTM As of Jun. 2024) - GuruFocus.com
A new trading data show Xeris Biopharma Holdings Inc (XERS) is showing positive returns. - SETE News
Xeris Biopharma Holdings (FRA:2B30) Cash-to-Debt : 0.29 (As of Jun. 2024) - GuruFocus.com
Xeris Biopharma Holdings (FRA:2B30) Long-Term Debt & Capita - GuruFocus.com
Xeris Biopharma (NASDAQ:XERS) Rating Reiterated by HC Wainwright - Defense World
Price T Rowe Associates Inc. MD Boosts Stock Position in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World
Xeris Biopharma Holdings (FRA:2B30) Momentum Rank : 1 (As of Aug. 16, 2024) - GuruFocus.com
Brokers Offer Predictions for Xeris Biopharma Holdings, Inc.’s Q3 2024 Earnings (NASDAQ:XERS) - Defense World
Q3 2024 EPS Estimates for Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Decreased by Analyst - MarketBeat
Insider Buying: Schmid John P., Xeris Biopharma Holdings Inc [XERS] Director invested 4,515 shares - Knox Daily
Xeris Biopharma Holdings (FRA:2B30) Enterprise Value : €553.2 Mil (As of Sep. 03, 2024) - GuruFocus.com
Xeris Biopharma Holdings (FRA:2B30) PS Ratio : 1.91 (As of Aug. 16, 2024) - GuruFocus.com
HC Wainwright Reaffirms "Buy" Rating for Xeris Biopharma (NASDAQ:XERS) - MarketBeat
Equities Analysts Offer Predictions for Xeris Biopharma Holdings, Inc.'s FY2027 Earnings (NASDAQ:XERS) - MarketBeat
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) to Post FY2027 Earnings of $0.27 Per Share, HC Wainwright Forecasts - Defense World
XERS (Xeris Biopharma Holdings) GF Value : $3.40 (As of Aug. 15, 2024) - GuruFocus.com
XERSXeris Biopharma Holdings, Inc. Latest Stock News & Market Updates - StockTitan
Xeris Biopharma Holdings Inc Azioni (XERS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.87%
1.31%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):